University of Crete (UOC)
In silico tumor growth validation based on human brain cancer models
Abstract
dc:descriptionGlioblastoma (GB) is the most malignant brain cancer and is not considered a curable disease so far. A multidisciplinary framework that integrates basic and translational research is presented targeting the validation of computer-based predictions of GB growth progress. Patient-specific cell cultures were established and used in experimental assays to assess GB pathophysiologic factors and parametrize/initialize/validate the computational predictive algorithms, accordingly.Focusing on proliferation, the combined in vitro-in silico approach supported that the intra-tumoral heterogeneity together with the overall proliferation reflected in both the proliferation rate and the mechanical cell contact inhibition, can predict the evolution of different GB cell lines.We showed that the primary GB spheroids adopt a novel, cohesive pattern mimicking perivascular invasion in the brain, while the U87MG and the T98G adopt a typical, starburst, invasive pattern. Our proposed mathematical approach suggested that allowing phenotypic heterogeneity within the tumor population is sufficient for variable invasive morphologies to emerge.GB adjuvant chemotherapy includes Temozolomide (TMZ); yet, not all patients are responsive. The latest trends in GB clinical trials usually refer to Doxorubicin (DOX); yet, it is unable to adequately overpass the blood brain barrier. A range of TMZ and DOX concentrations were used to treat the primary GB spheroids based on the IC50 values previously estimated in 2D. The effective concentrations of DOX and TMZ exhibit four orders of magnitude difference. In addition, we used Light Sheet Fluorescence imaging to visualize the drug penetration and necrosis. We observed that DOX was able to accumulatively cause necrosis, while in the TMZ-treated spheroids slight growth-inhibiting effects were observed in a non-consistent dose-response relationship. We have indications regarding the option of a TMZ-DOX therapeutic scheme to disable proliferation and increase cytotoxicity. An in vitro drug screening tool was proposed, while we followingly suggest to extend these observations to the hybrid discrete-continuous model. Overall, in this PhD thesis, we conclude that future research should be based on primary cells and that common cell lines should only serve as landmarks between different groups. Computational models may serve as predictor tools not only for estimating cancer progress, but also for designing targeted biological experiments and allow a better understanding of the involved biological phenomena. Simulations of cancer progress should not anymore be based on theoretical values, especially if clinical translation is of interest.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Oraiopoulou, Mariam-Eleni
- Ωραιοπούλου, Μαριάμ-Ελένη
Subjects
dc:subject × 20- Μεταφραστική έρευνα
- Φυσιολογία καρκίνου εγκεφάλου
- Γλοιοβλάστωμα
- Πρωτογενείς κυτταρικές καλλιέργειες
- Προβλεπτικοί αλγόριθμοι
- Translational research
- Brain cancer physiology
- Glioblastoma
- Primary cell cultures
- Predictive algorithms
- Φυσικές Επιστήμες
- Επιστήμη Ηλεκτρονικών Υπολογιστών και Πληροφορική
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Natural Sciences
- Computer and Information Sciences
- Biological Sciences
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44614